{
  "ticker": "ACRV",
  "success": true,
  "price": {
    "current": 1.88,
    "currency": "USD",
    "day_high": 1.895,
    "day_low": 1.83,
    "52_week_high": 8.0,
    "52_week_low": 1.05
  },
  "market_cap": {
    "value": 59323636.0,
    "currency": "USD"
  },
  "shares_outstanding": 31555126.0,
  "volume": {
    "last": 528235,
    "average_30d": 3503835
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -1.009396,
    "price_to_book": 0.46123648
  },
  "company_info": {
    "name": "Acrivon Therapeutics, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 145299000.0,
    "total_liabilities": 16696000.0,
    "stockholders_equity": 128603000.0,
    "cash": 35405000.0,
    "marketable_securities": 93849000.0,
    "total_liquidity": 129254000.0,
    "total_debt": 2989000.0,
    "long_term_debt": 1805000.0,
    "current_debt": 1184000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:29:21.626337",
    "url": "https://finance.yahoo.com/quote/ACRV",
    "data_hash": "50b3709f8d77255b"
  }
}